Prevalence of metabolic syndrome and associated factors in women aged 35 to 65 years who were enrolled in a family health program in Brazil

Menopause

Volumn 20, Issue 4, 2013, Pages 470-476

  Schmitt, Ana Carolina Basso ^a   Cardoso, Maria Regina Alves ^a   Lopes, Heno ^a   Pereira, Wendry Maria Paixão ^a   Pereira, Elaine Cristina ^a   De Rezende, Debora Aparecida Paccola ^a   Guarizi, Rubia Guibo ^a   Dellu, Mayra Cecilia ^a   De Moura Oliveira, Jéssica ^a   Flauzino, Erika ^a   Blümel, Juan E ^b   Aldrighi, José Mendes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Metabolic syndrome; Postmenopause; Premenopause; Prevalence

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ARTICLE; BRAZIL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERTENSION; HYPERURICEMIA; INTERVIEW; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PHYSICAL ACTIVITY; PREVALENCE; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SMOKING;

EID: 85028104698     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e318272c938     Document Type: Article

References (53)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428.
2. Ford ES, Giles WH. A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 2003;26: 575-581.
3. Aguilar-Salinas CA, Rojas R, Gómez-Perez FJ, et al. High prevalence of metabolic syndrome in México. Arch Med Res 2004;35:76-81.
4. Lopes HF. Síndrome metabólica: aspectos históricos, prevalência, e morbidade e mortalidade. Rev Soc Cardiol Estado São Paulo 2004;14: 539-543.
5. Qader SS, Shakir YA, Nyberg P, Samsioe G. Sociodemographic risk factors of metabolic syndrome in middle-aged women: results from a population-based study of Swedish women, The Women's Health in the Lund Area (WHILA) Study. Climacteric 2008;11:475-482.
6. Kannel WB, Hjortland MC, McNamara PM, et al. Menopause and risk of cardiovascular disease: the Framingham Study. Ann Intern Med 1978;85: 447-452.
7. Scuteri A, Ferrucci L. Blood pressure, arterial function, structure, and ageing: the role of hormonal replacement therapy in postmenopausal women. J Clin Hypertens (Greenwich) 2003;5:219-225.
8. Programa das Nações Unidas para o Desenvolvimento. Desenvolvimento Humano e Índice de Desenvolvimento Humano. Available at: http://www.pnud.org.br/atlas/ranking/IDH-Municipios-Brasil-2000.aspx? indiceAccordion=1&li=li-Ranking2003. Accessed February 2011.
9. Brasil. Constituioão (1988). Constituição da República Federativa do Brasil. Brasília, DF, Senado, 1988.
10. Brasil Ministério da Saúde. Pacto de Gestão do SUS. Brasília: Ministério da Saúde, 2006.
11. Brasil Ministério da Saúde. Sistema de Informaç ão da Atenção Básica. Available at: http//www.datasus.gov.Br/siab/siab.html. Accessed June 21, 2007.
12. Royer M, Castelo-Branco C, Blümel JE, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP-ATPIII): prevalence of the metabolic syndrome in postmenopausal Latin American women. Climacteric 2007;10:164-170.
13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
14. Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílio: Síntese de Indicadores 2004. Rio de Janeiro, Brazil: IBGE, 2005.
15. Sociedade Brasileira de Cardiologia. I Diretriz Brasileira de Diagnóstico e Tratamento da Síndrome Metabólica. Available at: http://www.scielo.br/pdf/abc/v84s1/a01v84s1.pdf. Accessed January 17, 2005.
16. Craig CL, Marshall AL, Sjostro M, et al. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-1395.
17. Giglioti A, Laranjeira R. Habits, attitudes and beliefs of smokers in four Brazilian capitals. Rev Bras Psiquiatr 2005;27:37-44.
18. Castro-Costa E, Ferri CP, Lima-Costa MF, et al. Alcohol consumption in late-life-the first Brazilian National Alcohol Survey (BNAS). Addict Behav 2008;33:1598-1601.
19. Block G, Gillespie C, Rosenbaum EH, Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med 2000;18:284-288.
20. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer J. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
21. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-491.
22. John MW. A new method for measuring daytime sleepiness: the Epworth Sleepness Scale. Sleep 1991;14:540-545.
23. Park HS, Oh AW, Cho S, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004;33:328-336.
24. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia. V Diretriz Brasileira de Hipertensão Arterial. Available at: http://www.nefrologiaonline.com.br/ Diretrizes/V-Diretrizes-Brasileiras-de-Hipertensao-Arterial.pdf. Accessed December 2, 2006.
25. British Hypertension Society. Validated blood pressuremonitors. Available at: http://www.bhsoc.org/blood-pressure-list.stm. Accessed June 5, 2005.
26. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
27. Morales DD, Punzalan FE, Paz-Pacheco E, Sy RG, Duante CA. National Nutrition and Health Survey: 2003 Group. Metabolic syndrome in the Philippine general population: prevalence and risk for atherosclerotic cardiovascular disease and diabetes mellitus. Diabetes Vasc Dis Res 2008;5:36-43.
28. Martínez MA, Puig JG, Mora M, et al. Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study. Metabolism 2008;57:1232-1240.
29. Fernández-Bergés D, Félix-Redondo FJ, Lozano L, et al. Prevalence of metabolic syndrome estimated with the new World Health Organization recommendations. The HERMEX study. Gac Sanit 2011;25:519-524.
30. Oliveira EP, Souza MLA, Lima MDA. Prevalência de síndrome metabólica em uma área rural do semi-árido baiano. Arq Bras Endocrinol Metab 2006;50:456-465.
31. Pimenta AM, Gazzinelli A, Velaquez-Melendez G. Prevalência da síndrome metabólica e seus fatores associados em área rural de Minas Gerais (MG, Brasil). Ciênc Saúde Coletiva 2011;16:3297-3306.
32. Salaroli LB, Barbosa GC, Mill JG, Molina MCB. Prevalência de síndrome metabólica em estudo de base populacional, Vitória, ES Brasil. Arq Bras Endocrinol Metab 2007;51:1143-1152.
33. Gronner MF, Bosi PL, Carvalho AM, et al. Prevalence of metabolic syndrome and its association with educational inequalities among Brazilian adults: a population-based study. Braz J Med Biol Res 2012;44:713-719.
34. López Suárez A, Elvira González J, Beltrán Robles M, et al. Prevalence of obesity, diabetes, hypertension, hypercholesterolemia and metabolic syndrome in over 50-year-olds in Sanlúcar de Barrameda, Spain. Rev Esp Cardiol 2008;61:1150-1158.
35. Berg G, Mesch V, Boero L, et al. Lipid and lipoprotein profile in menopausal transition: effects of hormones, age and fat distribution. Horm Metab Res 2004;36:215-220.
36. Schnell M, Dominguez ZA, Carrera C. Aspectos genéticos, clínicos y fisiopatológicos del síndrome metabólico. An Venez Nutr 2007;20:92-98.
37. Brasil Ministério da Saúde: Secretaria de Atenção à Saúde. Política Nacional de aten0ão Integral à Hipertensão Arterial e ao Diabetes Mellitus. Brasília: Ministério da Saúde, 2002.
38. Bompadre MC. Hipertensión en la postmenopausia. Rev Asoc Med Argent 2007;120:8-12.
39. Menon VU, Guruprasad U, Sundaram KR, Jayakumar RV, Nair V, Kumar H. Glycaemic status and prevalence of comorbid conditions among people with diabetes in Kerala. Natl Med J India 2008;21:112-115.
40. Brown TM, Vaidya D, Rogers WJ, et al. Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? J Womens Health 2008;17:841-847.
41. Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab 2007; 32:23-32.
42. Ford ES. Prevalence of the metabolic syndrome in US populations. Endocrinol Metab Clin North Am 2004;33:333-350.
43. Drapeau V, Lemieux I, Richard D, et al Waist circumference is useless to assess the prevalence of metabolic abnormalities in severely obese women. Obes Surg 2007;17:905-909.
44. Raimundo M, Lopes JA. Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. Cardiol Res Pract 2011;2011:1-16.
45. Nakazone MA, Pinheiro A, Braile MC, et al. Prevalence of metabolic syndrome using NCEP-ATPIII and IDF definitions in Brazilian individuals. Rev Assoc Med Bras 2007;53:407-413.
46. Feng Y, Hong X, Wilker E, et al. Effects of age at menarche, reproductive years, and menopause on metabolic risk factors for cardiovascular diseases. Artherosclerosis 2008;196:590-597.
47. Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. Obstructive sleep apnea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 2006;5:22.
48. Almeida GPL, Lopes HF. Síndrome metabólica e distúrbios do sono. Rev Soc Cardiol 2004;14:630-635.
49. Alam I, Lewis K, Stephens JW, Baxter JN. Obesity, metabolic syndrome and sleep apnea: all pro-inflammatory states. Obes Rev 2007;8:119-127.
50. Kawada T, Amezawa M. Effects of exercise and serum uric acid on the metabolic syndrome for Japanese workers. Metab Syndr Relat Disord 2008;6:137-141.
51. Lee HJ, Park HT, Cho GJ, et al. Relationship between uric acid and metabolic syndrome according to menopausal status. Gynecol Endocrinol 2011;27:406-411.
52. Kaduka LU, Kombe Y, Kenya E, et al. Prevalence of metabolic syndrome among an urban population in Kenya. Diabetes Care 2012;35:887-893.
53. Riediger ND, Clara I. Prevalence of metabolic syndrome in the Canadian adult population. CMAJ 2011;183:E1127-E1134.